# MSD Belzutifan PAS

> **NCT06554730** · — · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Von Hippel Lindau Disease

## Interventions

- **OTHER:** Belzutifan

## Key facts

- **NCT ID:** NCT06554730
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-06-30
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study is registered /active on RWD Catalogues (https://catalogues.ema.europa.eu) - Please refer to EU PAS number: EUPAS108114
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06554730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06554730, "MSD Belzutifan PAS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06554730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*